Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS productionAngela Mogavero(IFOM), Manuela Gariboldi(IFOM)Scientific ReportsNovember 16, 201710.1038/s41598-017-16149-zCited by 130SaveCiteExport RISWatch citationsRelated PapersmiR-342 overexpression results in a synthetic lethal phenotype in <i>BRCA1</i>-mutant HCC1937 breast cancer cells|Oncotarget|2016|23